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Background. More than 400 agents have been documented as causing occupational asthma (OA). The list of low-molecular-weight
(LMW) agents that have been identiﬁed as potential causes of OA is constantly expanding, emphasizing the need to continually
update our knowledge by reviewing the literature. Objective. The objective of this paper was to identify all new LMW agents
causingoccupationalasthmareportedduringtheperiod2000–2010.Methods.AMedlinesearchwasperformedusingthekeywords
occupational asthma, new allergens, new causes, and low-molecular-weight agents. Results. We found 39 publications describing 41
new LMW causal agents, which belonged to the following categories: drugs (n = 12), wood dust (n = 11), chemicals (n = 8),
metals (n = 4), biocides (n = 3), and miscellaneous (n = 3). The diagnosis of OA was conﬁrmed through SIC for 35 of 41 agents,
peak expiratory ﬂow monitoring for three (3) agents, and the clinical history alone for three (3) agents. Immunological tests
provided evidence supporting an IgE-mediated mechanism for eight (8) (20%) of the newly described agents. Conclusion. This
paper highlights the importance of being alert to the occurrence of new LMW sensitizers, which can elicit OA. The immunological
mechanism is explained by a type I hypersensitivity reaction in 20% of all newly described LMW agents.
1.Introduction
Occupational asthma (OA) is deﬁned as “a disease char-
acterized by variable airﬂow limitation and/or hyper-re-
sponsiveness and/or inﬂammation due to causes and condi-
tions attributable to a particular occupational environment
and not to stimuli encountered outside the workplace”
[1]. Two types of OA are distinguished based on their
appearance after a latency period or in absence of a latency
period. The most frequent type, which is usually quoted
as “occupational asthma,” appears after a latency period
eventually leading to sensitization (either allergic or through
unknown immunological mechanisms). The other category
does not require a latency period and includes irritant-
induced asthma or reactive airway dysfunction syndrome
(RADS), which may occur after single or multiple exposures
to high concentrations of nonspeciﬁc irritants [2].
The diagnosis of OA is often a challenge. A stepwise
approach is required to conﬁrm the diagnosis as recently
reviewed in a consensus statement of the American College
of Chest Physicians on diagnosis and management of work-
related asthma [3]. This includes a thorough questionnaire
on symptoms and work description, with objective conﬁr-
mation of the diagnosis of asthma, either by conﬁrming
reversible airﬂow obstruction or by documenting increased
nonallergic bronchial responsiveness (although the latter
may be absent if away from work). Immunological testings
(such as skin prick tests, documentation of speciﬁc IgE or
IgG)areusefultodocumentsensitizationbutdonotconﬁrm
thediagnosisofOA.Assessmentoftherelationshipofasthma
to work is done by monitoring of peak expiratory ﬂows,
methacholine or histamine inhalation challenges, sputum
induction at and oﬀ work, and/or by speciﬁc inhalation
challenges(SIC),whichareconsideredthereferencestandard
where available. The description of these methods is beyond
the scope of this paper and the reader can refer to the book
Asthma in the workplace published by Bernstein et al. [4]f o r
more details.
Asthma is one of the most prevalent respiratory diseases
in occupational settings. The prevalence of OA is estimated2 Journal of Allergy
between 10 and 16% of all new adult-onset asthma [3, 5–7].
Its incidence is estimated between 22 and 40 new cases per
million of active workers each year [8]. The ﬁnancial burden
of OA is very high. The total lifetime cost for all new cases of
OAdiagnosedin2003intheUKwasestimatedtobebetween
£70–100 million [9].
More than 400 distinct agents have been documented as
causing OA [10], and their number is steadily growing with
the development of industrial processes. However, knowing
which agents are potential airway sensitizers is an important
step for early identiﬁcation of OA among asthmatic patients
in order to adequately manage them and at the same
time, to prevent new cases from occurring. Classically, the
agents responsible for OA are divided according to their
molecular weight. High-molecular-weight (HMW) agents
(>10kDa [11]) include animal and vegetal origin proteins
and microorganisms. Low-molecular-weight (LMW) agents
are represented by wood dust, drugs, metals, and chemicals.
The mechanisms leading to immunological sensitization
to low molecular weight agents remain largely uncertain
[12].
The objective of the present study was to review all new
LMW agents causing occupational asthma with a latency
period reported between 2000 and 2010. This paper focused
on LMW agents given that two recent reviews had already
addressed the major HMW agents seen in the food and
seafood industry [13, 14], and that the most recent reviews
of LMW agents dated back to 2000 and 2001 [15, 16].
2. Methods
We searched Medline for publications or abstracts in English
using the keywords occupational asthma, new allergens, new
causes, and low-molecular-weight agents between 2000 and
2010.
3. Results
Thebibliographicsearchidentiﬁed39casereportsdescribing
41 new LMW agents causing OA during the period 2000–
2010. These agents are listed in Table 1. Among these 41
new LMW agents recognized as causing OA, twelve (12)
belonged to the Drugs category, eleven (11) to the Wood Dust
category, four (4) to the Metals category, and eight (8) to
the Chemicals category. We also found three (3) biocides,
two (2) fungicides, and one (1) anhydride salt classiﬁed as
miscellaneous.
Most of the identiﬁed articles are case reports or short
series, including a total of 62 subjects. Among these, 33
(53%) experienced concomitant rhinitis and four (4) (6%)
suﬀered from dermatitis (urticaria or contact dermatitis).
As shown in Table 1, the diagnosis workup included
monitoring of peak expiratory ﬂow (PEF) at and oﬀ work
in 29 (47%) cases, evaluation of nonspeciﬁc bronchial
responsiveness(NSBR)in52(84%)cases,anddetermination
of sensitization by skin prick tests (SPTs) in 26 (42%) cases
or speciﬁc immunoglobulin E (IgE) in 22 (35%) cases and
speciﬁc inhalation challenges (SIC) in 48 (77%) cases.
3.1. Drugs. Between 2000 and 2010, twelve (12) new drugs
were found to induce OA [17–28]( Table 1), including six
(6) antibiotic components: 7-aminocephalosporanic acid (7-
ACSA), 7-amino-3-thiomethyl-3-cephalosporanic acid (7-
TACA), cefteram, vancomycin, colistin, and thiamphenicol.
Three (15%) of these cases occurred in health care workers
and 15 (75%) in pharmaceutical employees.
The diagnosis was conﬁrmed by a positive SIC in 18 of
the 19 tested subjects with early (n = 10), late (n = 6),
and atypical (n = 1) reactions and was not speciﬁed in the
remaining case. The SIC was negative in one worker exposed
to sevoﬂurane and equivocal in the same worker exposed
to isoﬂurane. Sixteen (16) workers showed increased NSBR
and ﬁve (5) had signiﬁcant PEF variability at and oﬀ work.
As conﬁrmed by positive SPT and speciﬁc IgE, a type I
hypersensitivity reaction explained OA in workers exposed
to thiamphenicol, 7-ACSA, and cefteram.
In the case exposed to vancomycin powder [17], speciﬁc
SPT and IgE were negative, but positive intradermal reaction
and histamine release test suggested a direct histamine re-
leasing eﬀect of vancomycin instead of an IgE-mediated
mechanism.
While colistin is known to induce severe bronchospasm
by an unknown mechanism, especially in patients with cys-
tic ﬁbrosis [56], G´ omez-Oll´ es et al. reported a case of OA
and rhinitis due to inhalation of colistin in which the sub-
ject presented an immediate asthmatic reaction during the
SIC [18], the mechanism remaining unknown since the
determination of speciﬁc IgE was negative.
Park et al. described OA in two (2) workers exposed to 7-
ACSApowder(anintermediatemetaboliteofthesynthesisof
ceftriaxone) [19].Bothworkersdeveloped anearlyasthmatic
reaction when exposed to 7-ACSA but not when exposed
to ceftriaxone. Only one clearly had a type I allergic
reaction including a positive speciﬁc SPT, positive speciﬁc
IgE antibodies, and an immediate reaction during the SIC,
whereas the other had negative speciﬁc SPT and IgE.
Three(3)casesofOAinpharmaceuticalworkersexposed
to thiamphenicol (a derivative of chloramphenicol) were
reported,two(2)ofthemhavingpresentedatypeIhypersen-
sitivity reaction (positive speciﬁc SPT, positive speciﬁc IgE
antibodies, and an early reaction during the SIC) and the
third one, probably a non-IgE-mediated reaction (negative
speciﬁc SPT, speciﬁc IgE antibodies, and a late asthmatic
reaction) [20]. Other categories of drugs were identiﬁed as
being able to induce OA (Table 1).
3.2. Wood Dust. Eleven (11) new wood species have been
associated with OA [29–38]( Table 1), the majority being
exotic species originating from Africa, South America, or
A s i a .T h ec a s e sw e r er e p o r t e di nc a r p e n t e r sa n dw o o d
workers. Eight (8) of the twelve (12) reported patients (67%)
also had rhinitis and one (1) case had dermatitis. In all but
one of the subjects, the diagnoses had been conﬁrmed by a
positive SIC with early (n = 5), late (n = 3) and dual (n = 3)
reactions. The diagnosis of the remaining case (exposed to
sapele) was mainly based on history. Noticeably, the worker
exposed to cedroarana had a negative methacholine test
both before and after the SIC, despite an early asthmaticJournal of Allergy 3
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reaction [32]. Induced sputum analysis performed after the
SIC showed an increased eosinophil count in all of the four
(4) patients on whom this technique had been performed.
Speciﬁc SPTs were positive in four (4) out of nine (9)
patients. Speciﬁc IgE antibodies were positive in four (4)
of the eight (8) patients tested, conﬁrming a type I allergic
reaction for four (4), distinct wood species (cedroarana,
angelim pedra, antiaris and sapele).
3.3. Metals. F o u r( 4 )m e t a l sh a v eb e e nr e p o r t e da sc a u s a l
agents of OA [39–42]( Table 1). Most of the metals causing
OA belong to the transitional metal series. In the ﬁrst series
of transitional metals, chromium, cobalt, and nickel are all
known to induce OA [57–62]. Belonging to the same series,
manganese was shown to induce OA in a welder working in
at r a i nf a c t o r y[ 39].
Among the second series of transitional metals, palla-
diumisknowntocauseOA[63],whileMergetetal.reported
the ﬁrst case of OA and rhinitis induced by rhodium salts
[40] and conﬁrmed by an immediate asthmatic reaction
during the SIC. The positive SPT is compatible with a
type I hypersensitivity reaction although no speciﬁc IgE
were detected. Previous studies have shown cross-reaction
between platinum salts and rhodium; even though SPT and
SIC were positive for both platinum and rhodium in this
case, the authors concluded the absence of cross-reactivity.
Hannu et al. reported another case of OA in a welder
exposed to fumes from stellite [41], which is an alloy made
of cobalt (60%), chromium (30%), tungsten, and carbon.
A positive SIC conﬁrmed the diagnosis when the worker
was exposed to stellite welding fumes but not when he was
e x p o s e dt oc o b a l to rc h r o m i u ms o l u t i o n sa l o n e .
Mu noz et al. reported three (3) cases of OA induced by
iron metal welding [42]. The diagnoses were conﬁrmed by
SIC, eliciting in two out of three (2/3) workers an atypical
response with a rapid and persistent decline in lung function
over time and in the last one, a dual response. The analysis
of induced sputum revealed an increase in the neutrophil
count. Air analysis during the SIC found a high number of
metals and gases, none of these components (such as O3 or
NO2) exceeding the threshold limit values. Therefore, it is
diﬃcult to know which agent was the direct cause of OA in
this precise situation.
3.4. Chemicals. Among chemicals, eight (8) new agents
inducing OA have been reported for the period [43–50]
(Table 1). Among these, Vandenplas et al. documented a case
of OA and rhinitis due to uronium salt, a compound used
as a peptide coupling agent [43], ascertained by an early
asthmatic reaction during the SIC and positive SPT. They
also reported three (3) other workers with skin symptoms
and rhinitis, demonstrating positive SPT.
Occupational asthma was also documented with new
ﬂuxes replacing colophony in electronic settings, adipic acid,
and dodecanedioic acid gel [44, 45].
Hnizdo et al. reported an outbreak of OA in a chemical
plant, where six (6) cases of OA and rhinitis due to 3-amino-
5-mercapto-1,2,4-triazole, a chemical agent used in the
productionofherbicides,weredescribed[46].Thediagnoses
were based on history, increased NSBR, and monitoring of
PEF variability at and oﬀ work.
3.5. Biocides. Cases of OA to three (3) new biocides have
been reported [51–53]( Table 1) in healthcare workers.
Chlorine releasing agents are often used to disinfect
water in swimming pools. The role of these biocides is
questioned in the pathogenesis of asthma in swimmers
(both recreational and competitive) and children [64–66].
Thickett et al. published the case of two (2) lifeguards and a
swimming pool instructor working in three distinct indoor
swimming pools and diagnosed with OA [51]. Two (2)
of them had signiﬁcant PEF variability at work, and the
diagnosis was conﬁrmed in all of them by either SIC to
nitrogen trichloride (a compound of the chloramine family
which is found in swimming pool air) in two workers or
by a positive poolside challenge test. Two (2) of the workers
had normal NSBR when tested. A controlled case sensitized
to formaldehyde showed an early reaction when exposed to
nitrogen trichloride but not when exposed to distilled water,
suggesting that nitrogen trichloride could also be an irritant.
3.6. Miscellaneous. Draper et al. reported two (2) cases of
OA in subjects exposed to the new fungicides ﬂuazinam and
chlorothalonil [54] which induced late asthmatic reactions
during the SIC.
Keskinen et al. reported a case of OA due to chlorendic
anhydride (found in polyester paints) in a mechanic exposed
to welding fumes [55]. Chlorendic anhydride belongs to the
anhydride group, a group containing several compounds,
w h i c hc a nc a u s eO A .
4. Discussion
Forty-one (41) new LMW agents have been identiﬁed as
causes of OA for the period 2000–2010, which represents a
mean of four (4) new agents per year.
Ascertaining the presence of asthma through variable
airway obstruction and/or increased NSBR is usually con-
sidered the ﬁrst step of the diagnostic approach [3]. Such a
test is preferably conducted shortly after a period of work
exposure. Because of its high sensitivity, a negative test helps
in ruling out the diagnosis of asthma in a symptomatic
patient.Amongthecasesreportedduringthestudiedperiod,
increased NSBR was documented in forty-ﬁve (45) of the
ﬁfty-two(52)subjects(87%)whocompletedamethacholine
or histamine challenge. The NSBR test has been evalu-
ated only before SIC in thirty-two (32) subjects and was
increased in twenty-nine (29). In three (3) workers (exposed
to colistin, lasamide, and nitrogen trichloride), NSBR was
normal before SIC, but the test had not been repeated
after the positive challenge. For the remaining twenty (20)
workers, the NSBR evaluation had been performed before
and after SIC. Twelve (12) subjects had an increased NSBR
before SIC, which further increased after the challenge.
Four (4) subjects had a normal NSBR before SIC and
showed an increased NSBR after SIC and in the remaining
four (4), the challenge failed to demonstrate NSBR bothJournal of Allergy 7
before and after SIC (in workers exposed to cedroarana, 7-
TACA, nitrogen trichloride, and chlorothalonil). NSBR has
only been evaluated at and oﬀ work in three (3) subjects
exposed to iron fumes. Of the eleven (11) workers with
normal baseline NSBR, seven (7) were still being exposed at
work at the time of the assessment. The remaining four (4)
had already been moved to another workplace, which may
explainthenegativeresultofthechallenge.Amongtheeleven
(11) workers without baseline NSBR, three (3) (exposed to
5-ASA, uronium salt and eugenol) showed increased sputum
eosinophils, suggesting OA or occupational bronchitis.
Therefore, even in the absence of increased NSBR in OA,
there is a necessity to continue the diagnostic workup when
the history is highly suggestive of OA, especially when the
worker has been removed from his job.
Among the reviewed case reports, the diagnosis of OA
was conﬁrmed objectively with SIC, which is considered the
reference standard in the diagnosis of sensitizer-induced OA
[3, 67] for thirty-ﬁve (35) of the forty-one (41) described
agents. Diﬀerent types of asthmatic reactions have been
described in workers exposed to LMW, isolated late (23%) or
atypical(3%)reactionsbeing morefrequentwhencompared
to HMW agents (9% and 0%, resp.) [10, 68]. In this paper,
the SIC demonstrated an early asthmatic reaction in twenty-
two (22) workers (47%), an isolated late reaction in fourteen
(14) workers (30%), a dual reaction (an early followed
by a late reaction) in seven (7) workers (15%), and an
atypical reaction in only three (3) workers (6%). For three
(3) agents (vancomycin, 3-amino-5-mercapto-1,2,4-triazole
and chlorendic anhydride), the diagnosis was conﬁrmed by
PEF monitoring at and oﬀ work. Overall, PEF monitoring
was positive in 24/29 subjects. Serial peak expiratory ﬂow
monitoringisasimpleandinexpensivewaytoevaluatework-
related asthma with a sensitivity of 78% and a speciﬁcity
of 92% when using a computer-based pattern recognition
system like Oasys [69]. However, it has the disadvantage of
being eﬀort dependent, requiring careful supervision and
collaboration of the worker. In the three (3) remaining
agents (sapele, artiﬁcial ﬂavour, and orthophthalaldehyde),
the diagnosis was based solely on the clinical history and
improvement of symptoms away from work, without any
objective evidence of work-related asthma.
It is well established that the pathophysiology of OA due
to HMW allergens is similar to that of non-OA asthma,
involving a type I hypersensitivity reaction mediated by
speciﬁc IgE antibodies [11, 12]. Eosinophils are the key
inﬂammatory cells found in airway inﬂammation due to
HMW sensitizers. The clinical tests usually ﬁnd speciﬁc IgE
antibodies to the HMW agent, speciﬁc SPTs are positive, and
an increase in eosinophil count is often found in induced
sputum analysis after challenge exposure. The presence
of speciﬁc IgE antibodies has been demonstrated in OA
due to some LMW agents, for example, platinum salts or
acid anhydrides. However, for the vast majority of LMW
allergens, the immunological mechanism remains poorly
understood [70]. These LMW compounds act as haptens
that combine with self-proteins, creating new antigens
recognized as nonself by the immune system, and generating
a speciﬁc immune response [71]. In this paper, the presence
of speciﬁc IgE antibodies was documented for eight (8)
(20%) of the newly described agents, including thiampheni-
col, cefteram, 7-ACSA, cedroarana, angelim pedra, sapele,
antiaris, and chlorendic anhydride. Other postulated mech-
anisms involved are a direct histamine releasing eﬀect for
vancomycin-induced OA [17] or an IgG-mediated reaction
for falcate-induced OA [31].
Induced sputum analysis is a validated technique used to
assess airway inﬂammation in OA [72]. In OA due to LMW
agents, both eosinophils and neutrophils can be elevated,
together or separately. In the present paper, induced sputum
was assessed during SIC in twelve (12) patients, and a
postchallenge increase in eosinophil counts was documented
for eight (8) agents (5-ASA, tali, jatoba, bethabara, man-
ganese, uronium salts, eugenol, and peracetic acid-hydrogen
peroxide mixture), whereas an increase in neutrophil count
was recorded only for iron. Sputum samples were col-
lected 24h after SIC, except for bethabara and manganese
sampling, which took place the same day as SIC. The
measurement of exhaled nitric oxide (eNO) level has been
proposed as an alternative method for quantifying airway
inﬂammation, but its role in the occupational setting is
not well deﬁned [11, 71]. Only two (2) workers exposed
to 5-ASA and dodecanedioic acid, respectively, had such a
measurement; it showed an increase in eNO 24 hours after
SIC from 32 to 53ppb, associated with sputum eosinophilia
in the worker exposed to 5-ASA and a low result (14.3 ppb)
before SIC in the worker exposed to dodecanedioic acid.
In terms of symptoms, rhinitis is more frequently
associated with OA due to HMW allergens (92% of workers
with OA compared to 55% of workers exposed to LMW
agents) [10, 73]. Therefore, it is not surprising to note that
53% of the workers identiﬁed in this paper complained
of rhinitis symptoms. It is now believed that occupational
asthma and occupational rhinitis (OR) are part of the same
disease process [73, 74]. Moreover, OR can be considered a
risk factor in the development of OA, even if the proportion
of workers with OR eventually developing OA remains
uncertain [73].
According to recent reviews, the prevalence of OA tends
to be stable over time [75] or decrease in the last years [76,
77] in industrialized countries, although this may be due to
underreporting [78]. Despite this possible reduction in the
prevalenceofOAincertainindustries,newsensitizersarestill
reported each year. Therefore, vigilance is still required.
Predicting the risk of a new chemical agent as being
a potential respiratory sensitizer could be a useful tool in
the primary prevention of OA. The (quantitative) structure-
activity relationship model ((Q)SARs) has been developed
by the drug industry to evaluate the potential toxic eﬀect of
drugs in diﬀerent situations. The method is based on the link
between the chemical structure and the health eﬀects. Agius
et al. developed and validated the QSAR model to predict
the asthmagenic potential of LMW organic agents [79].
They showed that some chemical functional groups (i.e.,
nitrogen and oxygen containing groups such as isocyanate,
amine, acid anhydride, and carbonyl) were associated with
OA hazard, especially when these groups were present more
thanonceinthesamemolecule[80].Theirmodelwasableto8 Journal of Allergy
correctly identify 90% of LMW organic agents as asth-
magenic or not. Using a threshold hazard index of 0.5,
the sensitivity and speciﬁcity of the model in the exter-
nal validation group were 86% and 99% respectively,
while the negative predictive value was 100%. The model
can be accessed through the following web page: http://
www.coeh.man.ac.uk/research/asthma/. A hazard index has
been calculated for ﬁfteen (15) LMW out of the forty-
one (41) reported during the period 2000–2010 [80, 81].
The hazard index was surprisingly low for three (3) agents
(ﬂuazinam, sevoﬂurane, and eugenol), but for the twelve
(12) others, it ranged between 0.71 and 1, conﬁrming the
sensitizing hazard of these agents.
5. Conclusion
The list of LMW agents responsible for OA is continuously
growing as shown in this paper with forty-one (41) new
agents being reported during the period 2000–2010. The
involved immunological mechanisms are various and now
more often than before include IgE-mediated process in the
newly reported agents (20%).
Physicians should be cautious when diagnosing in that
they should not rely solely on lists of agents known to be
sensitizers when considering further investigation of workers
with work-related symptoms of asthma.
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